BGM014 Blood Glucose Monitoring System, BGM014 Pro Blood Glucose Monitoring System

System, Test, Blood Glucose, Over The Counter

APEX BIOTECHNOLOGY CORP.

The following data is part of a premarket notification filed by Apex Biotechnology Corp. with the FDA for Bgm014 Blood Glucose Monitoring System, Bgm014 Pro Blood Glucose Monitoring System.

Pre-market Notification Details

Device IDK161299
510k NumberK161299
Device Name:BGM014 Blood Glucose Monitoring System, BGM014 Pro Blood Glucose Monitoring System
ClassificationSystem, Test, Blood Glucose, Over The Counter
Applicant APEX BIOTECHNOLOGY CORP. NO. 7, LI-HSIN ROAD V HSINCHU SCIENCE PARK Hsinchu,  TW 30078
ContactHsue-mei Lee
CorrespondentHsue-mei Lee
APEX BIOTECHNOLOGY CORP. NO. 7, LI-HSIN ROAD V HSINCHU SCIENCE PARK Hsinchu,  TW 30078
Product CodeNBW  
Subsequent Product CodeJJX
Subsequent Product CodeLFR
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2016-05-09
Decision Date2016-12-23
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
10193489012453 K161299 000
20888277675688 K161299 000
10888277675698 K161299 000
00847713000794 K161299 000
00847713000787 K161299 000
00847713000817 K161299 000
00847713000800 K161299 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.